---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-333817"
form_type: "8-K"
ticker: "OFIX"
cik: "0000884624"
company_name: "Orthofix Medical Inc."
filed_at: "2026-08-05T11:03:20+00:00"
generated_at: "2026-08-05T11:06:07.831050+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Orthofix Q2 net sales $210.9M (+5% constant currency); raises FY2026 guidance

## Summary
- Q2 net sales $210.9M, up 5% pro forma constant currency YoY; GAAP net loss $(15.8)M ($0.39 loss per share).
- Non-GAAP adjusted EBITDA $20.1M (9.6% of sales) vs $20.6M (10.3%) prior year; margin slightly down.
- Raised FY2026 net sales guidance to $845M-$855M (from $838M-$848M) and adjusted EBITDA to $95M-$98M (from $90M-$93M).
- Global Limb Reconstruction grew 11% constant currency; Spine Fixation double-digit; Biologics stabilizing.
- Cash $104.4M, down from $120.9M due to arbitration payments to former executives.

## SEC filing metadata
- accession: 0001193125-26-333817
- form_type: 8-K
- ticker: OFIX
- cik: 0000884624
- company_name: Orthofix Medical Inc.
- filed_at: 2026-08-05T11:03:20+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/884624/000119312526333817/0001193125-26-333817-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/884624/000119312526333817/ofix-20260805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-333817
- JSON: https://secwatch.observer/filing/0001193125-26-333817.json
- Plain text: https://secwatch.observer/filing/0001193125-26-333817.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.